Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Mar 7;15:1391518. doi: 10.3389/fimmu.2024.1391518

Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes

Nyerhovwo Obarorakpor 1, Deep Patel 1, Reni Boyarov 1, Nansalmaa Amarsaikhan 1, Joseph Ray Cepeda 2, Doreen Eastes 1, Sylvia Robertson 1, Travis Johnson 1,3,4,5, Kai Yang 6,7, Qizhi Tang 8,9,10, Li Zhang 1,11,12,*
PMCID: PMC10959447  PMID: 38524122

In the published article, there was an error in the Funding statement. Grant “JDRF 2-SRA-2018-648-S-B” grant was missing in the statement. The correct Funding statement appears below.

Funding

This study was supported by grants from NIH R03AI139811-01A1, DoD W81XWH2210087, JDRF 2-SRA-2018-648-S-B, and a Pilot and Feasibility Award from the CDMD NIH/NIDDK Grant Number P30 DK097512 (to LZ).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES